James Hardie Industries (JHX) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
13 Apr, 2026Executive summary
Q3 FY26 net sales reached $1.24 billion, up 30% year-over-year, with strong contributions from the AZEK acquisition and organic net sales up 1%.
Adjusted EBITDA for the quarter was $330 million, up 26% year-over-year, with a margin of 26.6%.
Integration with AZEK is progressing ahead of schedule, generating meaningful commercial and cost synergies, with a $125 million synergy target reaffirmed.
Strategic focus remains on material conversion, innovation, and operational excellence to drive long-term value.
Adjusted diluted EPS was $0.24, down 31% year-over-year, reflecting higher share count and acquisition-related costs.
Financial highlights
Total net sales grew 30% to $1.24 billion, including $275 million from AZEK; organic sales up 1%.
Adjusted EBITDA was $330 million (26.6% margin); adjusted net income was $142 million; adjusted EPS $0.24.
Year-to-date free cash flow was $261 million, aided by a land sale in Australia; full-year free cash flow expected at least $200 million.
Net debt ended at $4.3 billion as of December 31, 2025; pro forma net leverage at ~3x, with a target to reduce below 2x within two years.
Operating income for Q3 FY26 was $176 million, down 15% year-over-year; adjusted net income was $142.2 million, down 7%.
Outlook and guidance
Raised full-year siding and trim net sales guidance to $2.953–$2.998 billion and Adjusted EBITDA to $939–$962 million.
Deck, Rail, and Accessories (DR&A) net sales guidance increased to $787–$800 million, with Adjusted EBITDA of $219–$224 million.
Total company Adjusted EBITDA guidance for FY26 is $1.232–$1.263 billion; free cash flow expected at least $200 million.
AZEK adjusted EBITDA (Q2–Q4) guided at $267–$275 million.
Expect organic revenue growth and margin expansion in FY27, with commercial and cost synergies supporting targets.
Latest events from James Hardie Industries
- Q2 FY26 sales jumped 34% on AZEK deal; margins fell, but FY26 outlook and synergies improved.JHX
Q2 20263 Feb 2026 - Q1 FY25 delivered record EBITDA, strong margins, and reaffirmed guidance amid market challenges.JHX
Q1 20252 Feb 2026 - H1 EBITDA topped $500m, FY25 guidance and buybacks raised despite lower sales.JHX
Q2 202514 Jan 2026 - FY25 met guidance; AZEK deal to drive $500M synergies; FY26 targets sales, EBITDA, and cash flow growth.JHX
H2 202514 Jan 2026 - Q3 FY25 delivered resilient margins, reaffirmed growth plans, and launched a new buyback program.JHX
Q3 20258 Jan 2026 - $8.75B merger targets $350M in synergies and forms a top building products growth platform.JHX
Business Combination27 Dec 2025 - Q1 FY26 sales fell 9%, AZEK acquisition closed, and early synergies are being realized.JHX
Q1 202623 Nov 2025 - Director re-elections and remuneration proposals faced rejection, while equity plans passed.JHX
AGM 202530 Oct 2025 - Merger with AZEK accelerates growth and market expansion through synergy and innovation.JHX
Jefferies Mining and Industrials Conference 202520 Oct 2025